Professor Kostas Syrigos graduated from the Athens School of Medicine in 1988. He completed his training in Internal Medicine at Laikon University Hospital (Athens School of Medicine, National and Kapodistrian University of Athens – NKUA), and subsequently specialized in Medical Oncology at Hammersmith Hospital (Imperial College of Medicine, Science and Art, University of London).

He received his MD with distinction from the Athens School of Medicine in 1995, and earned a PhD in Immuno-Oncology from Imperial College London in 2000. His clinical career includes positions as Senior Registrar in Medical Oncology at both Hammersmith and St Bartholomew’s Hospitals in London, as well as Consultant in the 3rd Department of Medicine at the ‘Sotiria’ General Hospital in Athens.

In 2002, he was appointed Associate Professor of Oncology in Medicine and became Head of the Sotiria Oncology Unit. Since 2008, he has served as Visiting Professor of Thoracic Oncology at Yale School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital (CT, USA), and since 2012 as Adjunct Professor of Medicine at the University of Pittsburgh School of Medicine (USA).

Since 2014, Professor Syrigos has led the 3rd Department of Medicine and Oncology Unit at the Athens School of Medicine, NKUA, based at ‘Sotiria’ General Hospital. In 2019, he was appointed Chair of the Faculty of Medicine at the Athens Medical School, NKUA.

He is the Director and Scientific Chair of two postgraduate programs leading to a Master’s degree (New Drug Development: Research, Approval & Access & Thoracic Oncology: Current Clinical & Laboratory Approach and Research).

His primary research interests include clinical oncology, drug development, immuno- oncology, and thoracic as well as head & neck cancers. He has participated in more than 200 international Phase I–IV clinical trials involving lung, head and neck, colorectal, breast, and pancreatic cancers. He has served as a Global Principal Investigator and member of numerous Scientific Steering Committees for international trials.

Professor Syrigos is an active member of several leading scientific societies, including the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), American College of Chest Physicians (ACCP), European Society of Medical Oncology (ESMO), European Respiratory Society (ERS), and the International Association for the Study of Lung Cancer (IASLC).

He has held editorial roles in numerous scientific journals, including co-editor of Oncology Research, editorial board member for over 25 journals, and reviewer for more than 100 journals. He is also the editor of 14 international scientific volumes.

According to Google Scholar, he has authored more than 1,210 peer-reviewed international publications and more than 100 book chapters, with over 49,000 citations, an h-index exceeding 109, and an i10-index above 515.

He currently serves as a member of the ESMO Translational Research Group, the IASLC Education Committee, and the ESMO Lung Cancer Faculty. In 2020, he established and continues to lead the Infectious Diseases Department at ‘Sotiria’ Hospital, dedicated to treating COVID-19 patients.

From March 2018 to April 2023, Professor Syrigos served as Chairman of the Board of Directors of SOS Children’s Villages Greece. He currently serves as Chairman of the Board of Directors of the Hellenic Association of Lung Cancer (HeALC).